TruSight™ Oncology 500 HRD at Oncopole Toulouse (France) ft. Dr. Guillaume Bataillon
TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer Dr. Guillaume Bataillon at Oncopole Toulouse why the center chose to bring TSO 500 HRD in-house to the laboratory.
*TruSight Oncology 500 not available in Japan
Subscribe to the Illumina video channel http://www.youtube.com/subscription_c...
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
View customer spotlight videos
• Illumina Customer Testimonials
View Illumina webinars
• Webinars
View Illumina product videos
• Playlist
View Illumina support videos
• Illumina Support
Facebook: / illuminainc
LinkedIn: / illu. .
Instagram: / illuminainc
Twitter: / illumina
#HRD #homologousrecombinationdeficiency #CGP #comprehensivegenomicprofiling #oncology #oncologytesting #Illumina #NGS #nextgenerationsequencing #biomarkers #pathology #TruSightOncology500 #TSO500 #TSO500HRD
